This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Cometriq
  • /
  • A Study of Cabozantinib (XL184) vs Everolimus in S...
Clinical trial

A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma (METEOR)

Read time: 1 mins
Last updated:1st Jun 2013
Register free for full access to medthority.com